Ea Series Trust Dynavax Technologies Corp Transaction History
Ea Series Trust
- $2.84 Trillion
- Q2 2023
A detailed history of Ea Series Trust transactions in Dynavax Technologies Corp stock. As of the latest transaction made, Ea Series Trust holds 183,977 shares of DVAX stock, worth $1.8 Million. This represents 0.08% of its overall portfolio holdings.
Number of Shares
183,977Holding current value
$1.8 Million% of portfolio
0.08%Shares
1 transactions
Others Institutions Holding DVAX
# of Institutions
294Shares Held
121MCall Options Held
294KPut Options Held
77.6K-
Black Rock Inc. New York, NY21.9MShares$215 Million0.01% of portfolio
-
Deep Track Capital, LP Greenwich, CT17.8MShares$174 Million6.26% of portfolio
-
Vanguard Group Inc Valley Forge, PA8.43MShares$82.6 Million0.0% of portfolio
-
State Street Corp Boston, MA6.4MShares$62.7 Million0.0% of portfolio
-
Chicago Capital, LLC5.23MShares$51.2 Million1.29% of portfolio
About DYNAVAX TECHNOLOGIES CORP
- Ticker DVAX
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 126,474,000
- Market Cap $1.24B
- Description
- Dynavax Technologies Corporation, a biopharmaceutical company, focuses on developing and commercializing novel vaccines in the United States. The company markets HEPLISAV-B, a hepatitis B vaccine for prevention of infection caused by all known subtypes of hepatitis B virus in age 18 years and older in the United States and Europe. It also manufa...